Search

Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria and the mechanisms of mycobacteria induced tumor immunity.

… We are broadly interested in the biology of mycobacteria, which include the major human pathogen M. tuberculosis , the nonpathogenic model organism M. smegmatis , and the cancer biotherapeutic agent BCG. Mycobacterium as Pathogen, Model System, and Cancer Therapy Our studies with M. tuberculosis seek

Frequently asked questions and answers about MSK's Mechanistic Biology Summer Program (MBSP) for college students.

… What is the purpose of the Mechanistic Biology Summer Program (MBSP)? What will MBSP interns do? Is the summer program limited to specific majors? Where is the internship located? Is this a paid internship? How many slots are available for this program? Is summer housing provided? What amenities are

… SK 809 Description HT-29 is a human colorectal adenocarcinoma cell line with epithelial morphology. These cells are sensitive to the chemotherapeutic drugs 5-fluorouracil and oxaliplatin, which are standard treatment options for colorectal cancer. In addition to being a xenograft tumor model for colorectal

… Job Title Assistant Attending Physician Degree MD

… Job Title Visiting Professor and Collaborator Professor of Mathematics, Dartmouth College 

… Job Title Associate Professor, SUNY Downstate Medical Center Degree PhD Start Year 1995 End Year 2002 Email [email protected]

When Memorial Sloan Kettering Cancer Center (MSK) opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment to the local community in the form of a 38,000-plus-square-foot addition complete with enhancements to both clinical programs and physical spaces.

… Monday, October 17, 2016 When Memorial Sloan Kettering opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment

Our relationship doesn’t end with treatment. Learn more about the support we offer through our Survivorship Center.

… Your doctor will want to continue to see you regularly for frequent follow-up exams for several years or longer. He or she will watch for side effects of treatment that can develop months to years after therapy has concluded (late effects), and for signs of the recurrence. During these check-ups, you

Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record.

… Tuesday, February 25, 2014 Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record following competitive reviews that concluded earlier this month. “For 130 years, Memorial Sloan Kettering has focused

Use this list of questions when talking to your doctor about joining a clinical trial.

… Use these questions as a starting point when talking to your doctor about participating in a clinical trial. Design of the Clinical Trial What is the purpose of this clinical trial? What phase is this clinical trial and what does that mean? Why do researchers believe this new treatment might be effective